News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Inside Information / Other news releases
Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders -
-
COMMUNIQUÉ DE PRESSE
Informations privilégiées / Autres communiqués
SSCL obtient une extension de contrat de plus de 300M£ pour fournir des services essentiels au gouvernement britannique pendant trois années supplémentaires. Sopra Steria et SSCL renforcent leur position sur le marché britannique avec un nouvel accord de 3 ans -
-
-
COMMUNIQUÉ DE PRESSE
Acquisition or disposal of the issuer's own shares / Description of the buyback program
Eurofins launches sixth buy-back programme of its own shares with plans to repurchase up to 4.5% of share capital. Programme starting on 25 April 2025 aims to hedge Long-Term Incentive plans and support other financial initiatives